BR100 Decreased By (-0.12%)
BR30 Decreased By (-0.52%)
KSE100 Decreased By (-0.01%)
KSE30 Decreased By (-0.03%)
AGHA 7.52 Increased By ▲ 0.04 (0.53%)
BECO 5.28 Decreased By ▼ -0.02 (-0.38%)
BML 57.40 Increased By ▲ 0.18 (0.31%)
BOP 33.85 Decreased By ▼ -0.07 (-0.21%)
CNERGY 11.02 Decreased By ▼ -0.08 (-0.72%)
CSIL 5.93 Decreased By ▼ -0.13 (-2.15%)
FCCL 55.47 Decreased By ▼ -0.43 (-0.77%)
FFL 16.18 Increased By ▲ 0.10 (0.62%)
FNEL 1.21 No Change ▼ 0.00 (0%)
KEL 7.26 Decreased By ▼ -0.04 (-0.55%)
KOSM 6.15 Increased By ▲ 0.05 (0.82%)
LOTCHEM 27.07 Decreased By ▼ -0.22 (-0.81%)
MLCF 96.40 Decreased By ▼ -1.05 (-1.08%)
NBP 204.45 Increased By ▲ 0.01 (0%)
NCPL 56.05 Decreased By ▼ -0.10 (-0.18%)
NPL 65.90 Decreased By ▼ -0.08 (-0.12%)
OGDC 315.94 Decreased By ▼ -3.15 (-0.99%)
PACE 10.65 Decreased By ▼ -0.01 (-0.09%)
PAEL 42.50 Decreased By ▼ -0.02 (-0.05%)
PIBTL 16.76 Decreased By ▼ -0.32 (-1.87%)
PPL 220.00 Decreased By ▼ -1.32 (-0.6%)
PRL 62.97 Decreased By ▼ -0.45 (-0.71%)
PTC 71.70 Decreased By ▼ -0.79 (-1.09%)
SSGC 27.55 Increased By ▲ 1.62 (6.25%)
TBL 9.72 No Change ▼ 0.00 (0%)
TELE 8.47 Increased By ▲ 0.01 (0.12%)
TPL 20.96 Decreased By ▼ -0.51 (-2.38%)
TPLP 15.16 Increased By ▲ 0.45 (3.06%)
TREET 23.29 Increased By ▲ 0.10 (0.43%)
TRG 61.05 Increased By ▲ 0.24 (0.39%)
By

ABUJA: Nigeria has become the first country in the world to roll out the “revolutionary” new Men5CV vaccine against meningitis, the World Health Organization (WHO) said.

Nigeria is one of the hotspots of the deadly disease in Africa. Last year, a 50% rise in annual cases was reported across 26 African countries regarded as meningitis hyperendemic countries, according to the WHO.

“Nigeria’s rollout brings us one step closer to our goal to eliminate meningitis by 2030,” Tedros Ghebreyesus, WHO Director General, was quoted as saying in a statement.

Between last October and mid-March this year, 1,742 cases were suspected in the country, with 153 deaths recorded in seven states in Nigeria, data from the WHO shows.

The new vaccine is reported to protect against the five major strains of the disease that are prevalent in Nigeria, unlike the initial vaccine that works against only one strain, said the WHO.

Comments

Comments are closed for this article.